Consequently, B cells may be significant in the prognosis of HNSCC patients and may work as a predictive biomarker for immunotherapy [ 51 ].
← all excerpts
Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma.
1
—
—